Revna Biosciences retweeted
Stay Informed: Know the Symptoms of Breast Cancer
#Breastcancer #pinkarmy #NBCC #Breastcancerawareness #breastcancer #breastcancerawarenessmonth #cancer #breastcancersurvivor #cancersucks #pink #pinkribbon #cancerawareness #cancersurvivor #survivor #brca #breastcancerwarrior
Revna Biosciences retweeted
Our CEO, Dr. Derrick Akpalu, was a keynote speaker at the Annual Convention for Biomedical Research, Ghana (CoBReG).
He shared insights into our research endeavours, challenges faced, and our commitment to advancing biomedical innovation and precision medicine
@Gh_Biomed #biomed
Revna Biosciences retweeted
A Step toward Eliminating Long-Standing European Bias in Precision Medicine
Researchers have taken a step toward making precision medicine more equitable by producing a catalog of gene expression data for non-European populations. Learn more: ow.ly/QM2w50SENBI
Revna Biosciences retweeted
GBS poses a major health risk as a common bacterial infection that can be transmitted from mother to child during childbirth. Addressing this issue through early detection and awareness is essential. #GBSAwarenes #ProtectOurBabies #MaternalHealth #RevnaBio #Africans
Revna Biosciences retweeted
Understanding Group B Streptococcus (GBS) is crucial for protecting our newborns. Awareness and early detection are key. Spread the word and educate others about the importance of GBS screening and prevention. Together, we can make a difference! 👇#GBSAwareness #Legon #WhatsApp
Revna Biosciences retweeted
Watch our patient-friendly animated video explaining the key concepts of Minimal Residual Disease (MRD). Understanding #MRD is important for patients, and this video breaks it down in an easy-to-follow way.
youtu.be/HA45YE_p-Po
#MRD #Myeloma
Revna Biosciences retweeted
AI Helps Spot Missed Breast Cancers
Using an AI-based scoring system to identify women for supplemental magnetic resonance imaging after negative mammography detects many missed breast cancers, interim trial findings indicate. Learn more: ow.ly/X8Mq50SxYjB
Revna Biosciences retweeted
Pangea Biomed’s AI Predicts Cancer Treatment Responses from Tumor Images
CEO Tuvik Beker explains how Pangea Biomed is using gene expression inferences from digital slide scans to make treatment suggestions. Learn more: ow.ly/hFoy50SuGGn
Revna Biosciences retweeted
Study Unveils Clues to the Pre-Metastatic Liver Environment in Pancreatic Cancer
The presence of large numbers of neutrophil extracellular traps in the pre-metastatic liver linked with a high risk of early metastasis in pancreatic cancer. Learn more: ow.ly/85LB50SwuTc
Revna Biosciences retweeted
Whole Genome Sequencing Improves Pediatric Cancer Care
Offering clinical whole-genome sequencing (WGS) to every child with suspected cancer changes the treatment plan in around one in 14 patients. Learn more: ow.ly/oFYR50SwuSp
Revna Biosciences retweeted
Next-generation liquid biopsy technologies that target the detection of cell-free DNA with fragments of circulating tumor DNA could be a game-changer in early cancer detection
Turning the tide of early cancer detection | Nature Medicine go.nature.com/4bw32E3
Revna Biosciences retweeted
Our August issue is out now at thelancet.com/gastrohep!
Including content on: biliary tract cancers, hepatitis B, infections in cirrhosis, gastric cancer, AI and precision endoscopy in inflammatory bowel disease, and much more…
#GITwitter #LiverTwitter #OncTwitter
Revna Biosciences retweeted
'Just scratching the surface: novel treatment approaches for multiple myeloma targeting cell membrane proteins' - New review by Kenneth Anderson, Paola Neri et al., now live online
Revna Biosciences retweeted
We are thrilled to launch new QIAcuity dPCR assays for microbial applications to target a wide range of pathogens responsible for tropical diseases, sexually transmitted infections, and urinary tract infections. Learn more 👉 tinyurl.com/mpbkffc9
Revna Biosciences retweeted
Results from several small clinical trials have suggested it may be possible to develop an effective immunotherapy for the brain cancer #glioblastoma. Among them are findings from a four-patient trial testing a unique type of mRNA cancer vaccine. go.nih.gov/tydGE8O #BTSM
Revna Biosciences retweeted
DNA Origami Selectively Triggers Cytotoxicity to Make Cancer Fold
Scientists have developed a cancer kill switch that triggers apoptosis when it is exposed to acidic tumor microenvironment. Learn more: ow.ly/b4os50Suys9
Revna Biosciences retweeted
📣 #ESMOGuideline #CLL eUpdate: 1st line time-limited ibrutinib–venetoclax, new MRD-driven Tx data, zanubrutinib in Tx-naive and r/r, more evidence on 1st line time-limited venetoclax–anti-CD20 antibody Tx
Check it now: 🔗 ow.ly/vzTz50Sulla
Revna Biosciences retweeted
Up to 13 million people in the US carry latent TB infection – and children are at increased risk for progression from infection to contagious active TB disease.
At what age is TB testing with modern TB blood tests recommended by the @AmerAcadPeds for children at risk for TB?
100%All ages
0%Age >2 years
0%Age >5 years
0%Age >17 years
2 votes • Final results Revna Biosciences retweeted
Osteoporosis Prediction Simplified with AI Model
A deep neural network model is able to predict early osteoporosis to a good level of accuracy and performs better than other models. Learn more: ow.ly/tUH650St71O





































